Why is Aristo Bio-Tech falling/rising?

As of 24-Sep, Aristo Bio-Tech & Lifescience Ltd is currently priced at 137.80, showing no change (0.00%). The stock has outperformed its sector by 0.32% today, although it has experienced a significant decline in investor participation, with delivery volume dropping by 75% compared to the 5-day average. Over the past month, the stock has increased by 24.03%, while year-to-date it has risen by 3.61%. However, the stock's performance over the last week shows a slight decline of 0.86%. The stock is trading above its 20-day, 50-day, 100-day, and 200-day moving averages, but it is below its 5-day moving average, indicating mixed signals regarding its short-term momentum.
In the broader market context, the Sensex has decreased by 1.08% over the past week, which suggests that while Aristo Bio-Tech has faced some challenges, it has managed to perform relatively better than the benchmark. Year-to-date, the Sensex has increased by 5.97%, which is higher than Aristo's 3.61% gain. This indicates that the stock's recent performance is somewhat isolated from the overall market trends, as it has shown resilience in the face of broader market declines. However, the falling investor participation could signal potential concerns among investors, which may impact future price movements.